Safety of preoperative erythropoietin in surgical calvarial remodeling: An 8-year retrospective review and analysis

Plastic and Reconstructive Surgery

Volumn 130, Issue 2, 2012, Pages

  Naran, Sanjay ^{a,b,c,d,e,f,g,h}   Cladis, Franklyn ^{a,b,c,d,e,f,g,h}   Fearon, Jeffrey ^{a,b,c,d,e,f,g,h}   Bradley, James ^{a,b,c,d,e,f,g,h}   Michelotti, Brett ^{a,b,c,d,e,f,g,h}   Cooper, Gregory ^{a,b,c,d,e,f,g,h}   Cray, James ^{a,b,c,d,e,f,g,h}   Katchikian, Hurig ^{a,b,c,d,e,f,g,h}   Grunwaldt, Lorelei ^{a,b,c,d,e,f,g,h}   Pollack, Ian F ^{a,b,c,d,e,f,g,h}   Losee, Joseph ^{a,b,c,d,e,f,g,h}  

^a Faculty Pavilion   (United States)

^b Department of Anesthesia ^*

^c Division of Plastic Surgery   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e Medical City Children's Hospital   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g PENNSYLVANIA STATE UNIVERSITY   (United States)

^h MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN;

ARTICLE; BLEEDING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; EVALUATION; FEMALE; HUMAN; INFANT; MALE; METHODOLOGY; MULTICENTER STUDY; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RETROSPECTIVE STUDY; SKULL; SYNOSTOSIS; THROMBOSIS; TREATMENT OUTCOME;

BLOOD LOSS, SURGICAL; ERYTHROPOIETIN; FEMALE; HEMATINICS; HUMANS; INFANT; MALE; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SKULL; SYNOSTOSIS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84865023293     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182589dbf     Document Type: Review

References (26)

1. Faberowski LW, Black S, Mickle JP. Blood loss and transfu-sion practice in the perioperative management of cranio-synostosis repair.J Neurosurg Anesthesiol. 1999;11:167-172.
2. Goodnough LT. Risks of blood transfusion. Crit Care Med. 2003;31(Suppl. 12):S678-S686.
3. Carver E. Blood loss during repair of craniosynostosis. Br J Anaesth. 2004;93:747; author reply 747.
4. Di Rocco C, Tamburrini G, Pietrini D. Blood sparing in cra-niosynostosis surgery. Semin Pediatr Neurol. 2004;11:278-287.
5. Fearon JA, Weinthal J. The use of recombinant erythropoi-etin in the reduction of blood transfusion rates in cranio-synostosis repair in infants and children. Plast Reconstr Surg. 2002;109:2190-2196.
6. Helfaer MA, Carson BS, James CS, Gates J, Della-Lana D, Vander Kolk C. Increased hematocrit and decreased transfu-sion requirements in children given erythropoietin before un-dergoing craniofacial surgery. J Neurosurg. 1998;88:704-708.
7. Velardi F, Di Chirico A, Di Rocco C. Blood salvage in cra-niosynostosissurgery. Childs Nerv Syst. 1999;15:695-710.
8. Krajewski K, Ashley RK, Pung N, et al. Successful blood conservation during craniosynostotic correction with dual therapy using procrit and cell saver. J Craniofac Surg. 2008; 19:101-105.
9. Stowell CP, Jones SC, Enny C, Langholff W, Leitz G. An open-label, randomized, parallel-group study of periopera-tive epoetin alfa versus standard of care for blood conserva-tion in major elective spinal surgery: Safety analysis. Spine 2009;34:2479-2485.
10. Janseen Products LP. Procrit Prescribing Information. Avail-able at: http://www.procrit.com/sites/default/files/pdf/ Procrit Booklet.pdf. Accessed June 18, 2012.
11. Eaton AC, Marsh JL, Pilgram TK. Transfusion requirements for craniosynostosis surgery in infants. Plast Reconstr Surg. 1995;95:277-283.
12. Steinbok P, Heran N, Hicdonmez T, Cochrane DD, Price A. Minimizing blood transfusions in the surgical correction of coronal and metopic craniosynostosis. Childs Nerv Syst. 2004; 20:445-452.
13. Meneghini L, Zadra N, Aneloni V, Metrangolo S, Faggin R, Giusti F. Erythropoietin therapy and acute preoperative normovolaemic haemodilution in infants undergoing craniosynostosis surgery. Paediatr Anaesth. 2003;13:392-396.
14. Przybylo HJ, Przybylo JH. The use of recombinant erythro-poietin in the reduction of transfusion rates in craniosynos-tosis repair in infants and children (Letter). Plast Reconstr Surg. 2003;111:2485-2486; author reply 2486-2487.
15. Dadure C, Sauter M, Bringuier S, et al. Intraoperative tranexamic acid reduces blood transfusion in children un-dergoing craniosynostosis surgery: A randomized double-blind study. Anesthesiology 2011;114:856-861.
16. Goobie SM, Meier PM, Pereira LM, et al. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: A dou-ble-blind, placebo-controlled trial. Anesthesiology 2011;114: 862-871.
17. Hanley JA, Lippman-Hand A. If nothing goes wrong, is ev-erythingall right? Interpretingzero numerators. JAMA 1983; 249:1743-1745.
18. Brandt JR, Avner ED, Hickman RO, Watkins SL. Safety and efficacy of erythropoietin in children with chronic renal failure. Pediatr Nephrol. 1999;13:143-147.
19. Erythropoietin safety concerns. Med Lett Drugs Ther. 2007; 49:37-39.
20. Crowther M, Radwi G. Erythropoietin-stimulating agents: On-goingconcernswithsafety. Am JKidney Dis. 2008;52:1039-1041.
21. Parker RI. Thrombosis in the pediatric population. Crit Care Med. 2010;38(Suppl. 2):S71-S75.
22. Jackson PC, Morgan JM. Perioperative thromboprophylaxis in children: Development of a guideline for management. Paediatr Anaesth. 2008;18:478-487.
23. Parasuraman S, Goldhaber SZ. Venous thromboembolism in children. Circulation 2006;113:e12-e16.
24. Schwarzkopf R, Chung C, Park JJ, Walsh M, Spivak JM, Steiger D. Effects of perioperative blood product use on surgical site infection following thoracic and lumbar spinal surgery. Spine 2010;35:340-346.
25. Bilgin YM, van de Watering LM,Versteegh MI, van Oers MH, Vamvakas EC, Brand A. Postoperative complications associ-ated with transfusion of platelets and plasma in cardiac sur-gery. Transfusion 2011;51:2603-2610.
26. Faris PM, Ritter MA. Epoetin alfa: A bloodless approach for the treatment ofperioperative anemia. Clin Orthop Relat Res. 1998;357:60-67.